Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria L Webb

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Bioorganic & Medicinal Chemistry Letters|August 17, 2010
Novel pyrrolidine heterocycles as CCR1 antagonistsJ Robert Merritt, Ray James, Vidyadhar M Paradkar, et al.
Journal of Medicinal Chemistry|December 28, 2002
Biphenylsulfonamide endothelin receptor antagonists. 4. Discovery of N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), a highly potent and orally active ET(A) selective antagonistNatesan Murugesan, Zhengxiang Gu, Steven Spergel, et al.
Journal of Medicinal Chemistry|February 3, 2009
Novel pyrrolidine ureas as C-C chemokine receptor 1 (CCR1) antagonistsJ Robert Merritt, Jinqi Liu, Elizabeth Quadros, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2011
Synthesis and SAR studies of novel 2-(6-aminomethylaryl-2-aryl-4-oxo-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonistsSusan E Napier, Jeffrey J Letourneau, Nasrin Ansari, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2009
2-Benzimidazolyl-9-(chroman-4-yl)-purinone derivatives as JAK3 inhibitorsAndrew G Cole, Adolph C Bohnstedt, Vidyadhar Paradkar, et al.
Arthritis and Rheumatism|May 28, 2010
Selective functional inhibition of JAK-3 is sufficient for efficacy in collagen-induced arthritis in miceTsung H Lin, Martin Hegen, Elizabeth Quadros, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
Synthesis and SAR studies of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonistsSusan E Napier, Jeffrey J Letourneau, Nasrin Ansari, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Bioorganic & Medicinal Chemistry Letters|August 17, 2010
Novel pyrrolidine heterocycles as CCR1 antagonistsJ Robert Merritt, Ray James, Vidyadhar M Paradkar, et al.
Journal of Medicinal Chemistry|December 28, 2002
Biphenylsulfonamide endothelin receptor antagonists. 4. Discovery of N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), a highly potent and orally active ET(A) selective antagonistNatesan Murugesan, Zhengxiang Gu, Steven Spergel, et al.
Journal of Medicinal Chemistry|February 3, 2009
Novel pyrrolidine ureas as C-C chemokine receptor 1 (CCR1) antagonistsJ Robert Merritt, Jinqi Liu, Elizabeth Quadros, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2011
Synthesis and SAR studies of novel 2-(6-aminomethylaryl-2-aryl-4-oxo-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonistsSusan E Napier, Jeffrey J Letourneau, Nasrin Ansari, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2009
2-Benzimidazolyl-9-(chroman-4-yl)-purinone derivatives as JAK3 inhibitorsAndrew G Cole, Adolph C Bohnstedt, Vidyadhar Paradkar, et al.
Arthritis and Rheumatism|May 28, 2010
Selective functional inhibition of JAK-3 is sufficient for efficacy in collagen-induced arthritis in miceTsung H Lin, Martin Hegen, Elizabeth Quadros, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2011
Synthesis and SAR studies of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonistsSusan E Napier, Jeffrey J Letourneau, Nasrin Ansari, et al.
Pageof 3